Coherus Biosciences (CHRS) stock forecast for 2022 – 2027

Are you interested in Coherus BioSciences, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CHRS stock price in 2022-2027. Is CHRS a good long term stock? When should I take profit in Coherus Biosciences stock? Buy or sell stock? Will CHRS stock price go up? What are analysts’ forecasts for CHRS stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CHRS stock returns are also predicted based on historical data.

According to our research, CHRS stock is a bad long-term investment. CHRS share price has been in a bear cycle for the past year. Coherus BioSciences, Inc. stock trend is negative.

Coherus Biosciences company info

Industry Biotechnology
Address 333 Twin Dolphin Drive, Redwood City, CA, 94065, United States
Website https://www.coherus.com

Forecasting

52 Week High: 16.3741 USD
52 Week Low: 11.4998 USD
1 Year Forecast: 12.2 USD
5 Year Forecast: 12.3568 USD

Agilent Technologies info

Market Cap: 949.07M
52 Week Change: -5.0613%
52 Week High: 21.56 USD
52 Week Low: 11.13 USD
Beta: 1.21554
50 Day Moving Average: 15.12
90 Day Moving Average: 16.458
200 Day Moving Average: 15.91
Resistance Level: 13.2121
Pivot Point: 12.212
Support Level: 11.5018
Enterprise Value: 1,174,022,784
Forward P/E: -12.96
Forward EPS: -0.92
Profit Margin: -63.71%
Shares Outstanding: 76,785,400
EBITDA: -5.99
Held Percent Institutions: 104.03%
PEG Ratio (5Y): 0.62
Trailing EPS: -3.12

Coherus Biosciences stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Coherus Biosciences Stock Forecast for 2022

March 2022 13.26 12 -9.5%
April 2022 11.88 11.88 0%
May 2022 12 13 8.33%
June 2022 12.74 13.26 4.08%
July 2022 13.13 14.85 13.1%
August 2022 15.3 16 4.58%
September 2022 16.16 13.86 -14.23%
October 2022 14.28 12.74 -10.78%
November 2022 12.74 11.88 -6.75%
December 2022 12.12 10.89 -10.15%

Coherus Biosciences Stock Forecast for 2023

January 2023 11.22 12.24 9.09%
February 2023 12 13.13 9.42%
March 2023 13 11.76 -9.54%
April 2023 11.88 11.88 0%
May 2023 12.24 13 6.21%
June 2023 13.26 12.87 -2.94%
July 2023 12.87 15.3 18.88%
August 2023 15.3 16.32 6.67%
September 2023 16.16 14.14 -12.5%
October 2023 14 14 0%
November 2023 12.74 11.76 -7.69%
December 2023 12.24 11.11 -9.23%

Coherus Biosciences Stock Forecast for 2024

January 2024 10.89 12.24 12.4%
February 2024 12 13 8.33%
March 2024 13 12.12 -6.77%
April 2024 12.12 11.76 -2.97%
May 2024 12.12 13.72 13.2%
June 2024 13.26 13.13 -0.98%
July 2024 13.26 14.7 10.86%
August 2024 15.15 16 5.61%
September 2024 16 14 -12.5%
October 2024 14.28 13.72 -3.92%
November 2024 12.87 12 -6.76%
December 2024 12.24 11.88 -2.94%

Coherus Biosciences Stock Forecast for 2025

January 2025 12.24 12.12 -0.98%
February 2025 12.12 12.87 6.19%
March 2025 13 12.12 -6.77%
April 2025 12.12 12 -0.99%
May 2025 12.12 14.28 17.82%
June 2025 14.14 13 -8.06%
July 2025 13 14.7 13.08%
August 2025 15 16 6.67%
September 2025 15.84 15.15 -4.36%
October 2025 15.15 13.86 -8.51%
November 2025 13.72 12.87 -6.2%
December 2025 12.87 12 -6.76%

Coherus Biosciences Stock Forecast for 2026

January 2026 12.24 12 -1.96%
February 2026 12 13.13 9.42%
March 2026 13.13 12.87 -1.98%
April 2026 13.26 11.76 -11.31%
May 2026 12.12 14 15.51%
June 2026 14.28 12.74 -10.78%
July 2026 13.13 16.16 23.08%
August 2026 15.84 16.16 2.02%
September 2026 15.84 15.3 -3.41%
October 2026 15 13.86 -7.6%
November 2026 14.28 13.13 -8.05%
December 2026 13.26 12 -9.5%

Coherus Biosciences Stock Forecast for 2027

January 2027 12.12 11.76 -2.97%